Mode
Text Size
Log in / Sign up
N/A N=4 Treatment

TMS for CRPS - Pilot Study

Complex Regional Pain Syndrome (CRPS)

Enrolled (actual)
4
Serious AEs
0.0%
Results posted
May 2017
Primary outcome: Primary: Change in Pain — 5.2; 0.7 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Transcranial Magnetic Stimulation (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Stanford University
Primary completion
Dec 2013

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Pain
5.2; 0.7
SECONDARY
Change in Motor Function and Coordination
SECONDARY
Change in Sensory Perception
SECONDARY
Change in Vasomotor Function
SECONDARY
Change in Sudomotor Function
SECONDARY
Trophic Changes
SECONDARY
Change in Motor Strength and Joint Range of Motion

Summary

The purpose of this pilot study is to test whether Transcranial Magnetic Stimulation (TMS) may alleviate the symptoms of Complex Regional Pain Syndrome (CRPS). The investigators will test various methods of TMS in a small pilot study to investigate what methods may have clinical potential. This is a small pilot study to determine feasibility and signal to potentially inform future trials.

Eligibility Criteria

Inclusion Criteria

  • Age 18 or older
  • Diagnosis of CRPS (complex regional pain syndrome)
  • Average pain level reported on Numerical Rating Scale meets entry criteria
  • Ability to perform the experimental task and procedures.

Exclusion Criteria

  • MRI contraindication (metal implants or devices, claustrophobia)
  • TMS Contraindication (eg metal implant or devices near the site of stimulation)
  • History of epilepsy
  • History of a psychological or psychiatric disorder that would interfere with study procedures, at the discretion of the researcher.
  • Neurologic illness that would interfere with brain integrity
  • Current medical condition or medication use that would interfere with study procedures or data integrity, at the discretion of the researcher.
  • Currently pregnant or planning to become pregnant.
  • On going legal action or disability claim.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01926119). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search